Open an account

Ludwig Enterprises

LUDG · OTC

$0.0035−$0.0035 (−50.00%)TodayMarket closed ·
Prev close $0.007

About LUDG

Ludwig Enterprises Inc, operates as a biotech and healthcare holding company. The company is headquartered in Pompano Beach, Florida and currently employs 5 full-time employees. The company went IPO on 2007-12-11. Its proprietary mRNA genomic technology has the potential of screening for genetic biomarkers for inflammatory-driven diseases, including, but not limited to, heart disease, diabetes, preeclampsia, cancer and long COVID. The firm employs a non-invasive cheek swab test to collect mRNA samples. Its initial product candidate is the Revealia Breast test, a non-invasive cheek swab assay designed to detect molecular signatures in mRNA expression associated with the presence of breast cancer. Its technology platform integrates three key components: non-invasive sample collection, genomic analysis, and machine learning-based interpretation.

Employees
5
Headquarters
Pompano Beach, Florida
Listed
Dec 11, 2007
Sector
Health Care
Industry
Biotechnology
Website
ludwigent.com

LUDG key statistics

Market cap
585.08K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
43.50K
Volume
25
Open price
$0.0038
High today
$0.005
Low today
$0.0027
52 Week high
$0.075
52 Week low
$0.0027

Ludwig Enterprises (LUDG) at a glance

As of Oct 16, 2026, Ludwig Enterprises (LUDG) shares are priced at $0.0035, giving the company a market cap of 585.08K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0027 and $0.005. The current price is 29.6% above the day's low and 30.0% below its high.

Volume so far is 25 shares, below the average of 43.50K shares a day.

Over the past year Ludwig Enterprises has ranged from $0.0027 to $0.075, and now sits 1% of the way up that range.

LUDG news

  • Press releaseACCESS Newswire

    Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer

  • Press releaseACCESS Newswire

    Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab

  • Press releaseACCESS Newswire

    Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology

  • Press releaseACCESS Newswire

    Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.

  • Press releaseACCESSWIRE

    Ludwig Enterprises Begins PCR Validation Test Process

  • Press releaseACCESSWIRE

    Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

  • Press releaseACCESSWIRE

    CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

  • Press releaseACCESSWIRE

    Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Similar companies

Companies in the same industry as Ludwig Enterprises

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.